These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6277215)

  • 1. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation.
    Hersman J; Meyers JD; Thomas ED; Buckner CD; Clift R
    Ann Intern Med; 1982 Feb; 96(2):149-52. PubMed ID: 6277215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures.
    Buckner CD; Clift RA; Thomas ED; Hersman J; Sanders JE; Stewart PS; Wade JC; Murphy M; Counts G; Meyers JD
    Infection; 1983; 11(5):243-50. PubMed ID: 6417027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic granulocyte transfusions.
    Buckner CD; Clift RA; Sanders JE; Hersman JA; Williams B
    Prog Clin Biol Res; 1982; 88():93-100. PubMed ID: 6285388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants.
    Clift RA; Sanders JE; Thomas ED; Williams B; Buckner CD
    N Engl J Med; 1978 May; 298(19):1052-7. PubMed ID: 417248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants.
    Navari RM; Buckner CD; Clift RA; Storb R; Sanders JE; Stewart P; Sullivan KM; Williams B; Counts GW; Meyers JD
    Am J Med; 1984 Apr; 76(4):564-72. PubMed ID: 6424464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection. An analysis of risk factors.
    Paulin T; Ringdén O; Lönnqvist B; Wahren B; Nilsson B
    Scand J Infect Dis; 1986; 18(3):199-209. PubMed ID: 3016884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
    Funada H; Harada M; Yoshida T; Hattori K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further experience with infections in bone marrow transplant recipients.
    Winston DJ; Meyer DV; Gale RP; Young LS
    Transplant Proc; 1978 Mar; 10(1):247-54. PubMed ID: 205022
    [No Abstract]   [Full Text] [Related]  

  • 9. Difference in onset between cytomegalovirus and idiopathic interstitial pneumonitis following allogeneic bone marrow transplantation for leukemia.
    Inoue T; Masaoka T; Shibata H
    Strahlenther Onkol; 1990 May; 166(5):322-5. PubMed ID: 2161566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symposium on infectious complications of neoplastic disease (Part II). Granulocyte transfusions.
    Clift RA; Buckner CD
    Am J Med; 1984 Apr; 76(4):631-6. PubMed ID: 6324588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic granulocyte transfusions during human bone marrow transplantation.
    Winston DJ; Ho WG; Young LS; Gale RP
    Am J Med; 1980 Jun; 68(6):893-7. PubMed ID: 6247910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
    Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
    Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.
    Meyers JD; Leszczynski J; Zaia JA; Flournoy N; Newton B; Snydman DR; Wright GG; Levin MJ; Thomas ED
    Ann Intern Med; 1983 Apr; 98(4):442-6. PubMed ID: 6301320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts.
    Neiman PE; Reeves W; Ray G; Flournoy N; Lerner KG; Sale GE; Thomas ED
    J Infect Dis; 1977 Dec; 136(6):754-67. PubMed ID: 21931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte transfusions in children.
    Pflieger H; Wiesneth M; Arnold R; Niethammer D; Kleihauer E
    Eur J Pediatr; 1981 Feb; 135(3):261-6. PubMed ID: 7014221
    [No Abstract]   [Full Text] [Related]  

  • 16. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.
    Mackinnon S; Burnett AK; Crawford RJ; Cameron S; Leask BG; Sommerville RG
    J Clin Pathol; 1988 Sep; 41(9):948-50. PubMed ID: 2848062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow transplantation for aplastic anemia and leukemia--review of results and blood product support required.
    Weiden PL; Slichter SJ; Banaji M
    Prog Clin Biol Res; 1978; 28():295-312. PubMed ID: 377308
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
    Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
    Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications of human bone marrow transplantation.
    Winston DJ; Gale RP; Meyer DV; Young LS
    Medicine (Baltimore); 1979 Jan; 58(1):1-31. PubMed ID: 368507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects of cytomegalovirus infection after allogenic bone marrow grafts].
    Gluckman E; Vilmer E; Devergie A; Mazeron MC; Pérol Y
    Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):337-44. PubMed ID: 6091225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.